Showing results (161-170 of 198) with videos related to

Sort By:
Pageof 20
Analytical Chemistry|March 2, 2021
Mass Spectrometry Imaging Reveals a Gradient of Cancer-like Metabolic States in the Vicinity of Cancer Not Seen in Morphometric Margins from MicroscopyMichael Woolman, Lauren Katz, Georgia Gopinath, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 25, 2018
Administration of Hypoxia-Activated Prodrug Evofosfamide after Conventional Adjuvant Therapy Enhances Therapeutic Outcome and Targets Cancer-Initiating Cells in Preclinical Models of Colorectal CancerJennifer Haynes, Trevor D McKee, Andrew Haller, et al.
Cancer Research|August 23, 2015
Identification of P450 Oxidoreductase as a Major Determinant of Sensitivity to Hypoxia-Activated ProdrugsFrancis W Hunter, Richard J Young, Zvi Shalev, et al.
Communications Biology|May 18, 2023
Identification of acquired Notch3 dependency in metastatic Head and Neck CancerMaria Kondratyev, Aleksandra Pesic, Troy Ketela, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|December 26, 2007
Antiproton radiotherapyNiels Bassler, Jan Alsner, Gerd Beyer, et al.
Molecular Pharmacology|April 14, 2019
Functional CRISPR and shRNA Screens Identify Involvement of Mitochondrial Electron Transport in the Activation of EvofosfamideFrancis W Hunter, Jules B L Devaux, Fanying Meng, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 23, 2015
Integrating RAS status into prognostic signatures for adenocarcinomas of the lungMaud H W Starmans, Melania Pintilie, Michelle Chan-Seng-Yue, et al.
Chemical Science|June 14, 2021
<i>In situ</i> tissue pathology from spatially encoded mass spectrometry classifiers visualized in real time through augmented realityMichael Woolman, Jimmy Qiu, Claudia M Kuzan-Fischer, et al.
Nature Communications|March 31, 2019
Targeting bivalency de-represses Indian Hedgehog and inhibits self-renewal of colorectal cancer-initiating cellsEvelyne Lima-Fernandes, Alex Murison, Tiago da Silva Medina, et al.
Journal of Enzyme Inhibition and Medicinal Chemistry|March 31, 2009
Taking advantage of tumor cell adaptations to hypoxia for developing new tumor markers and treatment strategiesPeter Ebbesen, Erik O Pettersen, Thomas A Gorr, et al.
Pageof 20